LeonaBio (LONA) Operating Leases (2020 - 2026)

LeonaBio (LONA) has 7 years of Operating Leases data on file, last reported at $213000.0 in Q1 2026.

• On a quarterly basis, Operating Leases fell 69.18% year-over-year to $213000.0 in Q1 2026; TTM through Mar 2026 was $213000.0, a 69.18% decrease from a year earlier, with the FY2025 full-year figure at $338000.0, down 57.91% from the prior year.
• Operating Leases for Q1 2026 stood at $213000.0, down from $338000.0 in the prior quarter.
• Over the last five years, Operating Leases for LONA reached as high as $1.8 million in Q2 2022 and fell as low as $213000.0 in Q1 2026.
• Historically, Operating Leases has averaged $1.1 million across 5 years, with a median of $1.1 million in 2024.
• Across the five-year window, Operating Leases fell 1.52% in 2022 and sank 69.18% in 2026, its largest moves.
• Year by year, Operating Leases stood at $1.6 million in 2022, then decreased by 23.22% to $1.2 million in 2023, then slumped by 34.02% to $803000.0 in 2024, then tumbled by 57.91% to $338000.0 in 2025, then tumbled by 36.98% to $213000.0 in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $213000.0 in Q1 2026, $338000.0 in Q4 2025, and $460000.0 in Q3 2025.